GLP-1 compounds

Details for Australian Patent Application No. 2012203915 (hide)

Owner Amgen Inc.

Inventors Gegg Jr., Colin Victor; Veniant-Ellison, Murielle; Miranda, Leslie Phillip; Winters, Katherine Ann

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012203915

Parent 2007240313

Filing date 4 July 2012

Wipo publication date 26 July 2012

International Classifications

C07K 14/605 Peptides having more than 20 amino acids

A61K 38/26 Medicinal preparations containing peptides - Glucagons

Event Publications

19 July 2012 Complete Application Filed

26 July 2012 Application Open to Public Inspection

  Published as AU-A-2012203915

30 August 2012 Section 223 Application Allowed

  Amgen Inc. The time in which to make a further application for a divisional patent has been extended to 02 Aug 2012 . Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203916-Systems and methods for estimating the geographic location at which image data was captured

2012203914-5imidazoquinolines and pyrimidine derivatives as potent modulators of VEGF-driven angiogenic processes